DeveloGen Aktiengesellschaft

City:

Goettingen

Country:

Germany

Published Applications:

Last publication date:

2013-09-05

Patent Grants:

Last grant date:

2015-05-12

Top Inventors for applications by DeveloGen Aktiengesellschaft

These are the the leading inventors for applications assigned to DeveloGen Aktiengesellschaft:

Matthias Austen 3 Goettingen, Germany
Thomas Siegmund 3 Landolfshausen, Germany
Daria Onichtchouk 2 Gottingen, Germany
Daria ONICHTCHOUK 2 Goettingen, Germany

Marcus Geese 2 Goettingen, Germany
Martin Schneider 2 Goettingen, Germany
Rainer Mussmann 2 Magden, Switzerland
Friedrich Harder 2 Lindau, Germany

Stephen Murfin 1 Didcot, United Kingdom
Arndt-René Kelter 1 Altfer, Germany
Babette Aicher 1 Voerde, Germany
Stefan Jaekel 1 Darmstadt, Germany

Babette Aicher 1 Frankfurt am Main, Germany
Steven Taylor 1 Didcot, United Kingdom
Kristin Aduroja 1 Dusseldorf, Germany
Matthias Austen 1 Gottingen, Germany

Thomas Stephen Coulter 1 Wantage, United Kingdom
Tanja Reuter 1 Darmstadt, Germany
Friedrich Harder 1 Gottingen, Germany
Friedrich Harder 1 Wasserburg, Germany

Bettina Rudolph 1 Hannover, Germany
Arndt-Rene Kelter 1 Alfter, Germany

Recent patent applications by DeveloGen Aktiengesellschaft

DeveloGen Aktiengesellschaft based in Goettingen, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-09-05

US20130231283A1

Chemistry; metallurgy

NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE

#2 | 2013-02-28

US20130053313A1

Human necessities

NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN

#3 | 2011-01-06 ✅ Patent 9,029,323 granted on 2015-05-12

US20110003741A1

Chemistry; metallurgy

Neurturin conjugates for pharmaceutical use

#4 | 2010-03-04 ✅ Patent 8,633,201 granted on 2014-01-21

US20100056548A1

Chemistry; metallurgy

Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositions

#5 | 2009-12-03

US20090298771A1

Human necessities

USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME

#6 | 2008-05-08

US20080107639A1

Human necessities

Use of a Dg147 Protein Product for Preventing and Treating Metabolic Disorders

#7 | 2007-05-17

US20070110728A1

Physics

Method for preventing and treating diabetes using dg119

#8 | 2007-05-10

US20070107073A1

Physics

Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome

AssigneeID:

11744 ⎘